Levothyroxine, considered to be the gold standard therapy for an underactive thyroid gland (hypothyroidism), stays to be the best after a new review of therapies for the condition, including combining levothyroxine with another agent. This claim is from a team of investigators. Their analysis, published as a set of guidelines in the journal emThyroid/em, finds insufficient consistent data exist to recommend a change in use of levothyroxine - whether generic, ...
Read More
No comments:
Post a Comment